Trials / Conditions / Stage IIC Melanoma
Stage IIC Melanoma
6 registered clinical trials studyying Stage IIC Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery NCT01748747 | Mayo Clinic | EARLY_Phase 1 |
| Withdrawn | Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Mela NCT01826864 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Completed | Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery NCT00669019 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma NCT00089063 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma NCT00085189 | University of Southern California | Phase 2 |
| Completed | Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma NCT00003895 | National Cancer Institute (NCI) | Phase 2 |